Second, both increased hepatic APOA4 synthesis due to hepatic steatosis and decreased APOA4 degradation in TFEB-deficient PTECs are likely the presumptive mechanism of APOA4 amyloidosis. The gene discussed is APOA4; the disease is fatty liver disease.